Background Thirteen COVID-19 vaccines are granted emergency approval. It is crucial to
monitor their adverse events post vaccination. The present study focuses on cardiovascular …

Abstract Background Coronavirus disease 19 (COVID-19) is the disease caused by SARS-
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …

In recent years, humanity has been confronted with a global pandemic due to coronavirus
disease 2019 (COVID-19), which has caused an unprecedented health and economic crisis …

Background: Fifteen COVID-19 vaccines have been granted emergency approval before the
completion of conventional phases of clinical trials. The present study aimed to analyze the …

Objective The aim of the study was to assess inflammatory markers and clinical outcomes in
adult patients admitted to hospital with mild-to-moderate COVID-19 and treated with a …

Objective In the COVID-19 pandemic, the SARS-CoV-2 virus has infected millions of people
worldwide. Mortality primarily results from the inflammation state and its complications. High …

Background: COVID-19 pandemic led to increased self-medication of antimicrobials,
vitamins, and immune boosters among the common people and consuming without …

COVID-19-infected patients require an intact immune system to suppress viral replication
and prevent complications. However, the complications of SARS-CoV-2 infection that led to …

Since December 2019, a novel coronavirus that represents a serious threat to human lives
has emerged. There is still no definite treatment for severe cases of the disease caused by …

Background This meta-analysis was conducted to investigate the impact of tocilizumab on
clinical outcomes associated with COVID-19. Methods A comprehensive search was …